The Research Institute of Molecular Pathology (IMP) is a leading basic research institute. Its 13 research groups with scientists from 40 countries address fundamental questions in molecular biology. Funded primarily by Boehringer Ingelheim and with unconstrained academic freedom, the IMP is the ideal environment for curiosity-driven biomedical research. As part of Vienna Bio Center, the IMP is embedded in one of Europe’s biggest life science hubs with over 3,000 people working on life science research, education, and business. Endorsements of the IMP by some of the World's most distinguished molecular biologists demonstrate that the IMP is among leading institutes of its kind. Since the IMP’s establishment in 1985, scientists at the institute are addressing important problems in research areas including molecular and cellular biology; structural biology and biochemistry; gene.
bioinformatics data analysishigh performance computingmechanical engineering and prototypingmicroscopy and imagingmonoclonal antibody productionpeptide synthesisprotein production and purificationProteomicsSanger sequencingtransgenic mouse production